- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Orphan products
- L-asparaginase encapsulated in erythrocytes
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
L-asparaginase encapsulated in erythrocytes
| EU orphan designation number: | EU/3/13/1106
|
| Active ingredient: | L-asparaginase encapsulated in erythrocytes |
| Indication: | Treatment of acute myeloid leukaemia |
| Sponsor: | ERYtech Pharma S.A.
60 avenue Rockefeller, Bâtiment Adenine, 69008 Lyon, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 12/02/2013 | Orphan designation | EMA/OD/167/12 | (2013)807 of 08/02/2013 |
CONTACT
EU links
Directorate General Health & Consumers